glp-1 and sarcopenia Glucagon‐like peptide‐1 receptor agonists muscle strength changes in older adults: Risks beyond muscle mass reductions - Prokopidis - British Journal of Pharmacology 💊💪 GLP-1 Weight Loss and

Nitrous oxide lawsuit claims center on manufacturers, distributors, and retailers who profit from selling canisters that are widely misused as a recreational drug

The research (Sara Stinson) uses large-scale genetic and metabolic data to show that Alzheimer's shares striking metabolic similarities with conditions such as obesity, type 2 diabetes and cardiovascular disease, whereas Parkinson's often points in the opposite direction

Preserving muscle helps support metabolism, strength, energy levels, and long-term weight maintenance

Ackeifi C, Swartz E, Kumar K et al

Escitalopram is often favored for its relatively clean side effect profile compared to older SSRIs